Skip to content

Clinical trials

Completed Urinary Bladder Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Status: Completed Country / region: Italy Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20031
20041
20052
20061
20072
20081
20093
20102
20112
20121
20131
20144
20152
20164
20171
20184
20194
20202
20212
20225
20231
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Hoffmann-La Roche5
Bristol-Myers Squibb4
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano3
Eli Lilly and Company2
Incyte Corporation2
Janssen Research & Development, LLC2
Merck Sharp & Dohme LLC2
UroGen Pharma Ltd.2
A.O.U. Città della Salute e della Scienza1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms55
Carcinoma, Transitional Cell13
Lung Neoplasms6
Non-Muscle Invasive Bladder Neoplasms6
Ovarian Neoplasms6
Urethral Neoplasms6
Prostatic Neoplasms5
Colorectal Neoplasms4
Kidney Neoplasms4
Neoplasm Metastasis4

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.